Patent · US Active

Treatment of malaria

US9737478B2 · kind B2 · utility

0Cited by

2References

3Claims

0Family size

Assignee

National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) · US

Inventors

Leonardo Jose de Moura Carvalho · Village of La Jolla, US
Pedro Cabrales · San Diego, US

Key dates

Filing date	Sep 13, 2010
Grant date	Aug 22, 2017
Priority date	—
Expiry date	Feb 12, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention contemplates compositions for the treatment of malaria comprising an anti-malaria drug and an adjuvant which promotes vasodilation and methods of using same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.